Credevo is a global Clinical Trial Organization (CTO) providing comprehensive clinical trial services for pharmaceuticals, biologics, medical devices and healthcare products. Based in Singapore, we operate across the Asia-Pacific region, the United States, and India. We provide strategic advisory, technical expertise, and full-scale operational support along with customized solutions for your clinical trial projects. Our core services include: - Trial Feasibility & Site Engagement: Leveraging an access of over 150,000 investigators and sites, we ensure efficient country strategy, site identification, and feasibility assessments. - Clinical Trials Strategy & Execution: Acting as your extended clinical development arm, we provide comprehensive support in the conceptualization, design, and execution of phase I-IV trials & BA/BE studies. - Products, Tools & Consultation: We offer a range of products and tools designed to support your clinical trials, along with consultancy services in clinical development to commercialization. As a CTO, we make planning and running clinical trials easier with solutions that fit your needs.
Looking for a particular Credevo employee's phone or email?
The Credevo annual revenue was $5 million in 2026.
Kshitij Soni is the Founder and CEO of Credevo.
7 people are employed at Credevo.
Credevo is based in Singapore, Central Singapore.
The NAICS codes for Credevo are [325, 3254, 32541, 32].
The SIC codes for Credevo are [283, 28].